
An examination of how this innovation is affecting pharmacy.
The MiniMed 770G system (Medtronic) is approved for use by individuals aged 2 to 6 with type 1 diabetes.
Abbott’s BinaxNOW COVID-19 Ag Card rapid test produces results in 15 minutes.
An examination of how telehealth services for medically underserved patients in rural areas improve access to pharmacists for chronic care management.
Is adherence packaging technology a big investment for a community or independent pharmacy?
Focus on best practices and implement new technology to safeguard against security breaches.
How pharmacists can address knowledge gaps and health literacy challenges to help people with chronic conditions stay adherent to drug therapies
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
Youth with diabetes who are involved in the decision to start continuous glucose monitoring reported consistent use 2 months after starting.
Here's the coronavirus-related news you should know from this week.
In episode 5 of Over the Counter, experts in technology and pharmacy highlight the major ways that telemedicine is rising to meet the COVID-19 pandemic.
A new computer model can help researchers predict the regional areas where vaccines are needed most.
Here's the coronavirus-related news you should know from this week.
Drug Topics interviews Steve Mok, PharmD, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence can mitigate challenges posed by the COVID-19 pandemic.
The FDA has granted emergency use authorization to an additional combination diagnostic test for influenza and COVID-19.
Drug Topics interviews Steve Mok, PharmD, BCPS, BCIDP, manager of pharmacy services and director of health outcomes and analytics fellowship at Wolters Kluwer, to break down the ways that artificial intelligence (AI) can mitigate challenges posed by the COVID-19 pandemic.
NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.
A new computer algorithm might be the next step toward accurate prediction of adverse drug reactions.
EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.
New findings from a study presented at the ADA’s 80th Scientific Sessions showed a dramatic drop in diabetic ketoacidosis hospitalizations in patients who used the FreeStyle Libre system
A poster presented at ADA’s 80th Scientific Sessions examines the effects of interactive pharmacist insulin teaching for patients with diabetes prior to hospital discharge.
Presented during ADA’s 80th Scientific Sessions, results from an analysis of a 6-month telehealth intervention showed sustained improvements in glycemic control in patients with diabetes.
Syndromic surveillance apps may be key in providing solutions to limitations on current COVID-19 case projection data collection efforts.
In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.
New digital health products are providing more insight into data and the opportunity for real-time patient interaction.
The free online tool aims to help individuals find alternative drug options for medications in shortage.
OmniSYS is providing all pharmacies free access to the OmniSYS Training Center™, which guides pharmacists through all aspects of the process to operationalize COVID-19 testing
Pharmacies that haven’t added digital marketing and advertising to their mix are missing the target.
Pharmacists can play an integral role in managing patients with diabetes.